Health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease

被引:25
作者
Chassany, O. [1 ]
Holtmann, G. [2 ]
Malagelada, J. [3 ]
Gebauer, U.
Doerfler, H. [4 ]
Devault, K. [5 ]
机构
[1] Hop St Louis, Assistance Publ Hop Paris, Dept Rech Clin & Dev, F-75010 Paris, France
[2] Univ Adelaide, Royal Adelaide Hosp, Adelaide, SA, Australia
[3] Hosp Univ Vall D Hebron, Barcelona, Spain
[4] Nycomed GmbH, Constance, Germany
[5] Mayo Clin, Jacksonville, FL 32224 USA
关键词
D O I
10.1111/j.1365-2036.2008.03683.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Although gastro-oesophageal reflux disease (GERD) has a well-established pathophysiology, the impact of GERD symptoms on the patients' quality of life can be profound. Therefore, health-related quality of life (HRQOL) questionnaires have become standard instruments to evaluate the effect of treatment in clinical trials. Aim To evaluate the reliability, validity and responsiveness of available GERD-specific HRQOL. Methods A systematic literature search using the Medical Subject Headings terms: 'Gastro-oesophageal reflux', 'Heartburn' and 'Oesophagitis' with 'quality of life' and 'questionnaires' was preformed to identify the available HRQOL questionnaires. To analyse the psychometric properties of the respective tools, the actual guidelines for the use of patient-reported outcomes in clinical trials were applied. Results We identified five GERD-specific HRQOL questionnaires but none of them fulfilled all quality criteria; either they did not meet the actual standards for psychometric properties (HBQOL, GERD-HRQL, Jasani et al. Aust Fam Physician 1999; 28: 515), or were impracticable to use in clinical trials. The generic and hybrid instruments lack specificity and sensitivity and were not designed for treatment evaluation in GERD patients. Conclusion There is need for a new evaluative tool in the assessment of HRQOL during GERD therapy.
引用
收藏
页码:1053 / 1070
页数:18
相关论文
共 50 条
  • [21] Gastro-oesophageal reflux disease
    de Carle, DJ
    MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (10) : 549 - 554
  • [22] Gastro-oesophageal reflux disease
    Fass, Ronnie
    Boeckxstaens, Guy E.
    El-Serag, Hashem
    Rosen, Rachel
    Sifrim, Daniel
    Vaezi, Michael F.
    NATURE REVIEWS DISEASE PRIMERS, 2021, 7 (01)
  • [23] Gastro-oesophageal reflux disease
    Bredenoord, Albert J.
    Pandolfino, John E.
    Smout, Andre J. P. M.
    LANCET, 2013, 381 (9881) : 1933 - 1942
  • [24] Gastro-oesophageal reflux disease
    Ronnie Fass
    Guy E. Boeckxstaens
    Hashem El-Serag
    Rachel Rosen
    Daniel Sifrim
    Michael F. Vaezi
    Nature Reviews Disease Primers, 7
  • [25] Gastro-oesophageal reflux disease
    Schmidt, C
    Baumeister, B
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (03) : 56 - 61
  • [26] Gastro-oesophageal reflux disease
    Moayyedi, Paul
    Talley, Nicholas J.
    LANCET, 2006, 367 (9528) : 2086 - 2100
  • [27] Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease
    Becher, A.
    El-Serag, H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (06) : 618 - 627
  • [28] Gastro-oesophageal reflux disease affects voice quality
    Pearson, J
    Abberton, E
    Fourcin, A
    Hashemi, M
    BRITISH JOURNAL OF SURGERY, 2005, 92 : 62 - 62
  • [29] Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma
    Carpagnano, GE
    Resta, O
    Ventura, MT
    Amoruso, AC
    Di Gioia, G
    Giliberti, T
    Refolo, L
    Foschino-Barbario, MP
    JOURNAL OF INTERNAL MEDICINE, 2006, 259 (03) : 323 - 331
  • [30] Oesophageal disorders and gastro-oesophageal reflux disease
    Tytgat, GNJ
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (01) : 9 - 11